Knorex Ltd.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $37.1M
- Price
- $0.3908
- % Change (Daily % change from the live per-ticker quote feed.)
- -0.76%
- Volume
- 33.6K
Quote data as of 7:06 AM ET
About
Knorex Ltd. is a technology company, provides online advertising software. Its product include knorex XPO, is a self-service enterprise-grade cloud platform with a comprehensive suite of advertising management and execution (AMX) applications. The company was founded on May 9, 2023 and is headquartered in Singapore.
Quick stats
Shares outstanding30.4M
Computed float16.2M
Float sourceUnknown
Cash runway (months)Unknown
Dilution risk—
Has warrants—
Has convertibles—
Active shelf (Shelf registration (e.g. Form S-3) currently in effect — the company is pre-cleared to issue and sell new shares quickly. A standing dilution risk.)—
Active ATM (At-the-market offering — a program to sell newly issued shares directly into the open market at prevailing prices, diluting existing holders over time.)—
Key info
SectorTechnology
IndustrySoftware - Application
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001982960
Websitehttps://www.knorex.com
AI Summary
AI-generated2mo agostandardbearishlate filingKNOREX Receives Notification from NYSE American Regarding Delayed Annual Report Filing
KNOREX received a non-compliance notice from NYSE Regulation after failing to file its fiscal 2025 Form 20-F by the extended May 15, 2026 deadline.
The exchange has established an Initial Cure Period until November 15, 2026, during which the company’s shares will continue to trade subject to other listing requirements.
Management cited time constraints in compiling and reviewing financial information as the cause for the delay and aims to file the report within the cure period.
Red flags
- Failed to file Form 20-F by extended deadline (May 15, 2026)
- NYSE non-compliance notice issued regarding continued listing standards
- Potential delisting risk if filing delinquency is not cured by November 15, 2026
- Generic explanation for delay citing 'time constraints' on financial statements